Newsletter | January 13, 2021

01.13.21 -- #NoGoingBack Supports Keeping Patients First

Featured Editorial
Industry Insights
Understanding Recent Updates To The Classification Of Rosacea

Since 2002, doctors and researchers have used a standard rosacea classification system to provide consistent terminology as well as to facilitate studies, clinical diagnosis, and treatment. However, in 2018, the Journal of the American Academy of Dermatology published a new standard classification system that replaces the previous one. Following is some of the most important information found in this publication.

Quality Metrics: How To Add Value And Meet The FDA's Expectations

Quality metrics have been widely used in the pharma industry to monitor quality systems and operational processes, and to promote continuous improvement initiatives in drug manufacturing.

The Evolution Of Patient Engagement And Remote Consenting In The COVID-19 Era

The COVID-19 pandemic further exacerbated some of the challenges associated with clinical trials, but it did fast track the adoption of decentralized trials as well as some of the associated technologies, such as the consent process, that enabled subjects to more easily participate remotely.

2021 State Of Clinical Trial Technology Industry Report

How are clinical operations leaders making strategic technology investments in 2021 and beyond? This report provides insights from more than 200 respondents to the annual Florence State of the Industry Survey, from dozens of stakeholders who are members of the Florence Executive Advisory Board, and more than 8,500 study sites and more than 8,000 sponsors using Florence.

Scaling Biometrics FSP

A small biotech was purchased by a large multinational biopharmaceutical company, and shortly thereafter closed the office of the former, leaving little to no resources for ongoing statistical programming to ensure continuity for their robust clinical development programs. To ensure limited disruption of the program, the sponsor engaged Catalyst to assume statistical programming services as they had no internal resources to dedicate. With Catalyst proving the ability to scale and provide exceptional programming talent the partnership continues to expand.

Home Health Nurse Network Ensures Patient Care Continuity During The COVID-19 Pandemic

Due to primary provider office closures, patients were unable to schedule their in-office subcutaneous injections required every six months. The client turned to UBC to design, structure, and operationalize a program using our nationwide network of registered nurses, which would transition in-office visits to a supportive and effective in-home setting.

Clinical Trials And Business Continuity In The Age Of COVID-19

In this webinar we are joined by Rahul Chaturvedi, an expert in clinical development with 10+ years of experience, who discusses some of the ways clinical trials are being disrupted and how to shift your mindset to take advantage of this time to strengthen your clinical program.

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.